Anthony M. Rimac

Insider Reports History

Entity
Individual
Location
C/O Adamas Pharmaceuticals, Inc., 2200 Powell St, Ste 220, Emeryville, CA
Signature
/s/ Dennis Hom, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anthony M. Rimac:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sagimet Biosciences Inc. Chief Operating Officer Stock Option (Right to Buy) 242K Jul 18, 2023 Direct

Insider Reports Filed by Anthony M. Rimac

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGMT Sagimet Biosciences Inc. Jul 18, 2023 2 $0 4 Jul 20, 2023 Chief Operating Officer
SGMT Sagimet Biosciences Inc. Jul 13, 2023 0 $0 3 Jul 13, 2023 Chief Operating Officer